
Pure Harvest Corporate Group, Inc. (PHCG)
ValueMarkers Composite Index
DCF data not available
Pure Harvest Corporate Group, Inc. (PHCG) — VMCI valuation read
Pure Harvest Corporate Group, Inc. (PHCG) carries a VMCI composite of 33/100, 17 points below the Healthcare sector median of 50. Among mid-cap names, that gap places PHCG in the bottom third on the five-pillar weighting (Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%).
The PHCG insider tape has been silent for the past 30 days on Form 4. Where executives neither buy nor sell, the bull and bear cases lean harder on filings cadence and the next earnings line.
**Investor frame.** Value reads PHCG trades at 14.0x earnings, 22% below the Healthcare median of 18.0x, which compresses or extends through the 11.0x EV/EBITDA versus a Healthcare 12.0x. Quality: ROIC of 14.0% sits 4.0pp above the Healthcare median (10.0%). Risk: net debt to EBITDA of 2.9x is the rate-sensitivity line to watch, the line to track on Pure Harvest Corporate Group, Inc.'s next 10-Q.
PHCG fell 0.3% over the trailing 7 days, with a -22.0% read on a 30-day basis.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.
- STMM - Stemcell Holdings, Inc.
- STMM - Stemcell Holdings, Inc.
- MHUA - Meihua International Medical Technologies Co., Ltd.
- MHUA - Meihua International Medical Technologies Co., Ltd.
- CHME - China Medicine Corporation
- CHME - China Medicine Corporation
- AZRX - AzurRx BioPharma, Inc.
- AZRX - AzurRx BioPharma, Inc.